Elevate Uranium Financials
| EL8 Stock | 0.29 0.01 3.33% |
Operating Margin -32.8 K | Return On Equity (0.92) |
Elevate | Select Account or Indicator |
Understanding current and past Elevate Uranium Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Elevate Uranium's financial statements are interrelated, with each one affecting the others. For example, an increase in Elevate Uranium's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Elevate Uranium's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Elevate Uranium. Check Elevate Uranium's Beneish M Score to see the likelihood of Elevate Uranium's management manipulating its earnings.
Elevate Uranium Stock Summary
Elevate Uranium competes with Westpac Banking, ABACUS STORAGE, Bisalloy Steel, JB Hi, and Pointsbet Holdings. Elevate Uranium is entity of Australia. It is traded as Stock on AU exchange.| Foreign Associate | Germany |
Specialization | Energy, Uranium |
| Instrument | Australia Stock View All |
| Exchange | Australian Securities Exchange |
| ISIN | AU0000156416 |
| Business Address | 28 Ord Street, |
| Sector | Oil, Gas & Consumable Fuels |
| Industry | Energy |
| Benchmark | Dow Jones Industrial |
| Website | www.elevateuranium.com.au |
| Phone | 61 8 6555 1816 |
You should never invest in Elevate Uranium without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Elevate Stock, because this is throwing your money away. Analyzing the key information contained in Elevate Uranium's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Elevate Uranium Key Financial Ratios
Elevate Uranium's financial ratios allow both analysts and investors to convert raw data from Elevate Uranium's financial statements into concise, actionable information that can be used to evaluate the performance of Elevate Uranium over time and compare it to other companies across industries.| Revenue | 182 | ||||
| Gross Profit | 116.86 K | ||||
| EBITDA | (10.62 M) | ||||
| Net Income | (10.75 M) | ||||
| Cash And Equivalents | 10.06 M |
Elevate Uranium Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 4.4M | 10.0M | 19.3M | 12.5M | 13.3M | 13.9M | |
| Other Current Liab | 283.8K | 188.8K | 566.5K | 487.9K | 300.4K | 157.7K | |
| Net Debt | (997.7K) | (6.6M) | (15.6M) | (9.9M) | (10.8M) | (10.2M) | |
| Retained Earnings | (52.5M) | (54.9M) | (60.6M) | (70.1M) | (80.8M) | (76.8M) | |
| Cash | 1.1M | 6.7M | 15.8M | 10.1M | 10.8M | 11.4M | |
| Net Receivables | 65.9K | 31.2K | 84.2K | 83.1K | 87.0K | 115.6K | |
| Total Liab | 435.0K | 429.5K | 838.6K | 1.0M | 1.5M | 949.0K | |
| Total Current Assets | 1.1M | 6.7M | 15.9M | 10.1M | 10.9M | 11.5M | |
| Common Stock | 55.9M | 64.0M | 78.0M | 78.2M | 88.0M | 92.4M | |
| Accounts Payable | 47.3K | 98.1K | 39.0K | 387.0K | 870.7K | 914.2K | |
| Inventory | (65.91) | (31.21) | (84.21) | (83.12) | (95.59) | (100.37) | |
| Other Current Assets | 65.91 | 31.21 | 84.21 | 83.12 | 74.81 | 71.07 | |
| Short Term Debt | 22.7K | 50.2K | 70.0K | 73.6K | 33.5K | 31.8K | |
| Long Term Debt Total | 42.5K | 49.1K | 107.2K | 72.4K | 65.2K | 61.9K | |
| Cash And Equivalents | 1.1M | 6.7M | 15.8M | 10.1M | 11.6M | 12.1M | |
| Net Tangible Assets | 3.9M | 9.5M | 18.5M | 11.5M | 13.2M | 7.8M | |
| Net Invested Capital | 3.9M | 9.5M | 18.5M | 11.5M | 13.2M | 8.2M | |
| Net Working Capital | 775.1K | 6.4M | 15.2M | 9.2M | 10.6M | 6.0M | |
| Capital Stock | 55.9M | 64.0M | 78.0M | 78.2M | 89.9M | 72.0M |
Elevate Uranium Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Operating Income | (1.9M) | (2.7M) | (5.8M) | (7.9M) | (10.5M) | (10.0M) | |
| Ebitda | (1.7M) | (2.7M) | (5.7M) | (8.5M) | (10.6M) | (10.1M) | |
| Income Before Tax | (1.7M) | (2.6M) | (5.7M) | (8.6M) | (10.8M) | (10.2M) | |
| Net Income | (1.7M) | (2.6M) | (5.7M) | (8.6M) | (10.8M) | (10.2M) | |
| Income Tax Expense | (2.9K) | 4.3K | 2.2K | (50.2K) | (255.7K) | (268.5K) | |
| Ebit | (1.8M) | (2.7M) | (5.8M) | (8.6M) | (10.7M) | (10.2M) | |
| Interest Expense | 2.9K | 5.7K | 8.8K | 8.6K | 8.2K | 7.8K | |
| Total Revenue | 22.21 | 116.9K | 119.7K | 319.7K | 287.7K | 200.1K | |
| Gross Profit | (46.0K) | (54.3K) | (85.5K) | (117.7K) | (121.7K) | (127.8K) | |
| Cost Of Revenue | 46.0K | 54.3K | 85.5K | 117.7K | 121.7K | 115.6K | |
| Interest Income | 24.2K | 31.6K | 6.6K | 27.0K | 24.3K | 23.1K | |
| Net Interest Income | 2.9K | (4.3K) | (2.2K) | 220.2K | 253.2K | 265.9K |
Elevate Uranium Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 575.1K | 5.6M | 9.2M | (5.8M) | 776.1K | 814.9K | |
| Free Cash Flow | (1.8M) | (2.4M) | (4.5M) | (5.9M) | (9.3M) | (8.8M) | |
| Capital Expenditures | 302.3K | 61.3K | 113.0K | 74.5K | 62.4K | 59.3K | |
| End Period Cash Flow | 1.1M | 6.7M | 15.8M | 10.1M | 10.8M | 11.4M | |
| Depreciation | 46.0K | 54.3K | 85.5K | 117.7K | 121.7K | 127.8K | |
| Other Non Cash Items | 284.2K | 166.9K | 806.8K | 3.4M | 2.0M | 2.1M | |
| Net Income | (1.7M) | (2.6M) | (5.7M) | (8.6M) | (10.8M) | (10.2M) | |
| Change To Netincome | 168.2K | 131.1K | 960.3K | 3.1M | 3.5M | 3.7M | |
| Investments | (302.3K) | (61.3K) | (137.6K) | (74.5K) | (85.7K) | (90.0K) |
Elevate Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elevate Uranium's current stock value. Our valuation model uses many indicators to compare Elevate Uranium value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elevate Uranium competition to find correlations between indicators driving Elevate Uranium's intrinsic value. More Info.Elevate Uranium is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elevate Uranium's earnings, one of the primary drivers of an investment's value.Elevate Uranium Systematic Risk
Elevate Uranium's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Elevate Uranium volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Elevate Uranium correlated with the market. If Beta is less than 0 Elevate Uranium generally moves in the opposite direction as compared to the market. If Elevate Uranium Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Elevate Uranium is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Elevate Uranium is generally in the same direction as the market. If Beta > 1 Elevate Uranium moves generally in the same direction as, but more than the movement of the benchmark.
Elevate Uranium Total Assets Over Time
Elevate Uranium December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Elevate Uranium help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Elevate Uranium. We use our internally-developed statistical techniques to arrive at the intrinsic value of Elevate Uranium based on widely used predictive technical indicators. In general, we focus on analyzing Elevate Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Elevate Uranium's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 23.33 | |||
| Value At Risk | (9.68) | |||
| Potential Upside | 10.71 |
Additional Tools for Elevate Stock Analysis
When running Elevate Uranium's price analysis, check to measure Elevate Uranium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevate Uranium is operating at the current time. Most of Elevate Uranium's value examination focuses on studying past and present price action to predict the probability of Elevate Uranium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevate Uranium's price. Additionally, you may evaluate how the addition of Elevate Uranium to your portfolios can decrease your overall portfolio volatility.